Fentora- Possible Approval for NON-cancer Neuropathic Pain

July 5, 2012

I'm still exhausted from my PCP appointment, so I have not been on top of my

inbox, but I had to forward this.

Cephalon has applied for FDA approval of Fentora (patented fentanyl

immediate release product) for non-cancer BTP (Breakthrough Pain), which means

that (if it is approved) insurance companies could no longer deny non-cancer

patients access to Fentora simply for the fact that they do not have a cancer

diagnosis!!!

I believe that this is a response to the new REMS program (old REMS

programs did not cover Fentora, Actiq, or generics). Cephalon manufacturers

Fentora, Actiq, and all but two of the generic OTFC (generic Actiq).

FDA approval can take 10-12 months and the press release is dated November 12,

2011, so it could be approved by the end of the year! Once approved, more

doctors will likely be educated on it and prescribe it more and then the price

will likely go down and then more insurance companies will cover it. I know, I

know, I should not hold my breath but I need to convince myself it will happen.

Fentora may taste like crap, but if it helps half as much as Actiq, or is beyond

worth it.

Cephalon Submits Supplemental New Drug Application for FENTORA

bit'.'ly/MCMYnL

Link is case sensitive, just replace '.' with . and the link should work fine.

If you have trouble with the link, please email me off board (some messages

boards do not permit clickable links)

Steve M in PA

Recommended Posts